Picture a client who has invested in a traditional equity mutual fund for years, suddenly asking why their statement doesn’t show the granular daily pricing for the customized hedging instruments held within their new, more complex Specialized Investment Fund (SIF) strategy. You find yourself explaining that while exchange-traded derivatives are governed by the strict, public disclosure norms of the stock exchange, the Over-the-Counter (OTC) market operates on a different plane of transparency.
On an exchange, every price tick and volume change is broadcast in real-time, ensuring that every participant, from the smallest retail investor to the largest institution, sees the same valuation. This public ledger is the foundation of market integrity, allowing you to confidently guide clients through their daily NAV fluctuations in a standard mutual fund scheme.
In contrast, OTC transactions are private arrangements negotiated directly between two counterparties, such as a bank and an asset management company. Because these contracts are tailored to specific duration and risk needs—perhaps hedging a unique exposure that a standard exchange contract cannot match—they do not circulate on a public ticker. The transparency here is limited to the parties involved, meaning the ‘market price’ for such a derivative is not a single, universally observable number.
For a distributor, this distinction is vital when discussing portfolio risks with a client, as the lack of public price discovery in OTC instruments means you must rely on the periodic valuation disclosures provided by the fund manager rather than real-time market data.
This difference directly influences the suitability assessment process for high-net-worth investors or those exploring SIFs. When you recommend a strategy that utilizes significant OTC derivatives, you are essentially asking the client to trust the creditworthiness and valuation methodology of the counterparty rather than the protective umbrella of a clearing corporation. You must ensure the client understands that while flexibility allows for more sophisticated risk management, it carries an inherent transparency gap compared to the public derivatives market.
Failing to communicate this difference can lead to confusion when a client attempts to verify their portfolio valuation through external, public sources that simply do not record these bespoke private contracts.
Ultimately, transparency is a trade-off between the standardized safety of public markets and the bespoke functionality of private agreements. As a distributor, your role is to bridge this gap, ensuring the client views OTC positions not as opaque ‘black boxes’ but as specialized tools that serve a clear purpose within their overall risk-adjusted mandate. When you simplify these complex concepts, you transform a potentially confusing disclosure document into a clear demonstration of why their investment strategy is being managed with such precision.
Nuance
Check Your Understanding
A client holding an investment in a SIF asks why they cannot track the daily market value of an interest rate swap held in the portfolio on a public exchange website. How should you respond?
Which of the following best describes the fundamental difference in market transparency between exchange-traded and OTC derivatives?
This is a companion read for Section 13.5 — Types of Derivatives Market from Pass Certification Examination for Mutual Fund - Specialized Investment Fund Distributors by Akhilesh Gururani, available on Amazon Kindle.
Copyright © 2026 Akhilesh Gururani. All rights reserved.